NASDAQ:BMRA Biomerica (BMRA) Stock Price, News & Analysis → A lot of people are making this costly mistake (From WealthPress) (Ad) Free bmra Stock Alerts $0.83 -0.06 (-6.73%) (As of 03/28/2024 ET) Add Compare Share Share Today's Range$0.82▼$0.9550-Day Range$0.85▼$1.2952-Week Range$0.70▼$2.13Volume83,946 shsAverage Volume86,199 shsMarket Capitalization$13.99 millionP/E RatioN/ADividend YieldN/APrice TargetN/A Stock AnalysisStock AnalysisChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSocial MediaStock AnalysisChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSocial Media Get Biomerica alerts: Email Address Ad Crypto 101 MediaSHOCKING Crypto Leak…A shocking leak has revealed tech giant Microsoft's plans to add crypto support to future products. If the plans in these leaked internal documents pan out, we could see prices skyrocket for Bitcoin, Ethereum, XRP and MORE… The coupling of gaming and cryptocurrency could absolutely transform digital finance as we know it in 2024. Claim your free seat by clicking here now. About Biomerica Stock (NASDAQ:BMRA)Biomerica, Inc., a biomedical technology company, develops, patents, manufactures, and markets diagnostic and therapeutic products for the detection and/or treatment of medical conditions and diseases worldwide. The company's diagnostic test kits are used to analyze blood, urine, nasal or fecal specimens from patients in the diagnosis of various diseases, food intolerances, and other medical complications; or to measure bacteria, hormones, antibodies, antigens, or other substances which may exist in the human body, stools, or blood in extremely small concentrations. It primarily sells its products for gastrointestinal diseases, food intolerances, and various esoteric tests at the physicians' offices and over-the-counter drugstores, and hospital/clinical laboratories. The company is also developing InFoods IBS, that uses a simple blood sample to identify patient-specific foods which may alleviate irritable bowel syndrome symptoms; and H. Pylori diagnostic test that indicates if a patient is infected with the H. Pylori bacteria. In addition, it develops products to indicate if a person has been infected by COVID-19. Biomerica, Inc. was incorporated in 1971 and is headquartered in Irvine, California.Read More BMRA Stock Price History View Price History Chart DataSkip Price History Chart 30 days | 90 days | 365 days | Advanced Chart BMRA Stock News HeadlinesMarch 28, 2024 | globenewswire.comBiomerica InFoods IBS Data to be Presented at the Upcoming Digestive Disease Week (DDW) 2024 ConferenceMarch 26, 2024 | americanbankingnews.comBiomerica (NASDAQ:BMRA) Stock Price Passes Below Two Hundred Day Moving Average of $0.99March 28, 2024 | Crypto 101 Media (Ad)Altcoin FRENZY Alert…Bitcoin recently crossed the highest price in its 15-year history… Less than 2 years after one of the most vicious crypto market meltdowns we've ever seen! Bitcoin's BOOM also sent shockwaves through the altcoin market, with select coins seeing HUGE moves in a matter of days… Like Fetch.ai, that gained over 350% in just the last 30 days… March 10, 2024 | morningstar.comBiomerica Inc BMRAFebruary 23, 2024 | benzinga.comBiomerica Stock (NASDAQ:BMRA), Short Interest ReportFebruary 21, 2024 | finance.yahoo.comDiagnostics Industry Leader Gary Huff Appointed to Biomerica Strategic Advisory BoardFebruary 21, 2024 | globenewswire.comDiagnostics Industry Leader Gary Huff Appointed to Biomerica Strategic Advisory BoardFebruary 20, 2024 | barrons.comBiomerica Inc.March 28, 2024 | WealthPress (Ad)$25,000 into $109,616 in two months? Today I want to show you how our research shows you could’ve grown a $25,000 account into $109,616.12 within the last TWO months. You see, former multi-million dollar hedge fund manager Roger Scott spent the better half of 2023 developing what might be the most advanced trading tool that exists… It’s a revolutionary software system that tracks the moves of institutional investors…. in real time…February 17, 2024 | finance.yahoo.comBMRA Mar 2024 2.500 callFebruary 5, 2024 | benzinga.comBiomerica Stock (NASDAQ:BMRA) Dividends: History, Yield and DatesJanuary 23, 2024 | finance.yahoo.comDiagnostics Industry Leader Jack Kenny Appointed as Chairman of the Board at BiomericaJanuary 16, 2024 | markets.businessinsider.comBiomerica Reports Second Quarter 2024 Financial ResultsDecember 20, 2023 | finance.yahoo.comIs Biomerica (NASDAQ:BMRA) In A Good Position To Deliver On Growth Plans?December 19, 2023 | msn.comBiomerica swings 501(k) clearance for H. pylori bacteria diagnostic testDecember 18, 2023 | markets.businessinsider.comNasdaq Gains 100 Points; Biomerica Shares Spike HigherDecember 18, 2023 | msn.comWhy Is Diagnostics Products Focused Biomerica Stock Trading Higher Today?December 18, 2023 | finance.yahoo.comBiomerica Received US FDA 510(k) Clearance for Their Hp Detect™ ELISA Test Product Designed to Detect the Presence of the H. pylori Bacteria That infects Approximately 35% of the U.S. PopulationNovember 10, 2023 | tmcnet.comBiomerica to Participate in 14th Annual Craig-Hallum Alpha Select Conference on November 16November 8, 2023 | finance.yahoo.comBiomerica Expands inFoods IBS Reach with Addition of Several New GI GroupsOctober 13, 2023 | markets.businessinsider.comREPEAT - Biomerica Reports First Quarter 2024 Financial ResultsOctober 13, 2023 | finanznachrichten.deBiomerica, Inc.: Biomerica Reports First Quarter 2024 Financial ResultsOctober 13, 2023 | markets.businessinsider.comBiomerica Reports First Quarter 2024 Financial ResultsSeptember 26, 2023 | tmcnet.comDubai Government Grants Insurance Reimbursement for Biomerica's EZ Detect™ Colorectal Disease Screening TestSeptember 26, 2023 | finance.yahoo.comDubai Government Grants Insurance Reimbursement for Biomerica’s EZ Detect™ Colorectal Disease Screening TestAugust 28, 2023 | tmcnet.comDiagnostics Industry Leader Jack Kenny Joins Biomerica's Board of DirectorsAugust 27, 2023 | finance.yahoo.comBiomerica Full Year 2023 Earnings: US$0.50 loss per share (vs US$0.36 loss in FY 2022)See More Headlines Receive BMRA Stock News and Ratings via Email Sign-up to receive the latest news and ratings for Biomerica and its competitors with MarketBeat's FREE daily newsletter. Email Address Company Calendar Last Earnings1/16/2024Today3/28/2024Next Earnings (Estimated)4/12/2024Fiscal Year End5/31/2024Get Stock AlertsIndustry, Sector and Symbol Stock ExchangeNASDAQ SectorMedical Industry Diagnostic substances Sub-IndustryN/A Current SymbolNASDAQ:BMRA CUSIPN/A CIK73290 Webwww.biomerica.com Phone(949) 645-2111Fax949-553-1231Employees62Year Founded1971Profitability EPS (Most Recent Fiscal Year)($0.38) Trailing P/E RatioN/A Forward P/E RatioN/A P/E GrowthN/ANet Income$-7,140,000.00 Net Margins-110.58% Pretax Margin-109.15% Return on Equity-64.25% Return on Assets-50.98% Debt Debt-to-Equity RatioN/A Current Ratio5.63 Quick Ratio4.62 Sales & Book Value Annual Sales$5.34 million Price / Sales2.62 Cash FlowN/A Price / Cash FlowN/A Book Value$0.70 per share Price / Book1.19Miscellaneous Outstanding Shares16,820,000Free Float14,551,000Market Cap$13.99 million OptionableOptionable Beta-1.01 Social Links 7 Stocks to Own Before the 2024 ElectionLooking to avoid the hassle of mudslinging, volatility, and uncertainty? You'd need to be out of the market, which isn’t viable. So where should investors put their money? Find out with this report.Get This Free Report Key ExecutivesMr. Zackary S. Irani (Age 58)Chief Executive Officer Comp: $141.25kMr. Allen C. Barbieri (Age 66)Executive Vice-Chairman of the Board & Corporate Secretary Comp: $126.25kMr. Gary Lu CPA (Age 43)Principal Accounting Officer & CFO Comp: $260kMs. Lucy Liu Ph.D.Director of Manufacturing & Technical OperationsMr. Robert W. CarlsonChief Commercial OfficerKey CompetitorsTrinity BiotechNASDAQ:TRIBARCA biopharmaNASDAQ:ABIOOncoCyteNASDAQ:OCXNavidea BiopharmaceuticalsNYSE:NAVBMyMD PharmaceuticalsNASDAQ:MYMDView All CompetitorsInsiders & InstitutionsVanguard Group Inc.Bought 42,833 shares on 3/11/2024Ownership: 3.622%Granahan Investment Management LLCSold 80,148 shares on 2/15/2024Ownership: 6.437%Vanguard Group Inc.Bought 42,833 shares on 2/15/2024Ownership: 3.623%Heritage Investors Management CorpSold 35,750 shares on 2/7/2024Ownership: 0.206%Russell Investments Group Ltd.Bought 26,288 shares on 2/5/2024Ownership: 1.198%View All Insider TransactionsView All Institutional Transactions BMRA Stock Analysis - Frequently Asked Questions How have BMRA shares performed in 2024? Biomerica's stock was trading at $1.25 at the beginning of 2024. Since then, BMRA shares have decreased by 33.4% and is now trading at $0.8320. View the best growth stocks for 2024 here. Are investors shorting Biomerica? Biomerica saw a decrease in short interest in March. As of March 15th, there was short interest totaling 76,700 shares, a decrease of 42.5% from the February 29th total of 133,500 shares. Based on an average trading volume of 102,500 shares, the days-to-cover ratio is presently 0.7 days. View Biomerica's Short Interest. When is Biomerica's next earnings date? The company is scheduled to release its next quarterly earnings announcement on Friday, April 12th 2024. View our BMRA earnings forecast. How were Biomerica's earnings last quarter? Biomerica, Inc. (NASDAQ:BMRA) issued its quarterly earnings data on Tuesday, January, 16th. The company reported ($0.09) earnings per share for the quarter. The firm earned $1.57 million during the quarter. Biomerica had a negative net margin of 110.58% and a negative trailing twelve-month return on equity of 64.25%. What other stocks do shareholders of Biomerica own? Based on aggregate information from My MarketBeat watchlists, some companies that other Biomerica investors own include Sorrento Therapeutics (SRNE), Pfizer (PFE), Johnson & Johnson (JNJ), OPKO Health (OPK), TG Therapeutics (TGTX), Advanced Micro Devices (AMD), Co-Diagnostics (CODX), FuelCell Energy (FCEL) and Trevena (TRVN). Who are Biomerica's major shareholders? Biomerica's stock is owned by a number of institutional and retail investors. Top institutional investors include Granahan Investment Management LLC (6.44%), Vanguard Group Inc. (3.62%), Vanguard Group Inc. (3.62%), Russell Investments Group Ltd. (1.20%), Heritage Investors Management Corp (0.21%) and Concourse Financial Group Securities Inc. (0.00%). Insiders that own company stock include Allen Barbieri, Catherine Coste and Zackary S Irani. View institutional ownership trends. How do I buy shares of Biomerica? Shares of BMRA stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services. Compare Top Brokerages Here. This page (NASDAQ:BMRA) was last updated on 3/28/2024 by MarketBeat.com Staff From Our PartnersGrab Your Free Bitcoin Today!Crypto Swap ProfitsMake This $3 Trade the Instant the Opening Bell RingsMonument Traders AllianceTop Project Outperforms BTC in 2023…Crypto 101 MediaFed launches fourth dollar overhaulStansberry ResearchBREAKING: New AI Breakthrough Could Change Healthcare ForeverBehind the MarketsThis AI Trade Machine Made 1,729%* (With 89% Wins)Prosper Trading Academy“The Stock Market’s Bull Run is Far from Over” -BarronsVertical Research AdvisoryMost important medical advance in 100 yearsThe Oxford Club Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Biomerica, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Your Password: or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Choose a Password: Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.